Illumina Pays Complete Genomics $325M To End DNA IP Row
After a Delaware federal jury determined Illumina willfully infringed DNA sequencing patents held by Complete Genomics Inc. and owes $334 million — a figure that could be tripled — CGI's Chinese...To view the full article, register now.
Already a subscriber? Click here to view full article